Citations for
1CYP2D6
Identification of genetic variants of human cytochrome P450 2D6 with impaired mitochondrial targeting.
Sangar MC, Anandatheerthavarada HK, Martin MV, Guengerich FP, Avadhani NG.
Mol Genet Metab 99(1):90-7. Epub .PMID: 19781968 2010
2CYP2D6, CYP2D6DM
CYP2D6 polymorphism in relation to tramadol metabolism: a study of faroese patients.
Halling J, Weihe P, Brosen K.
Ther Drug Monit 30(3):271-5. 2008
3CYP2D6, CYP2E1, GSTM1
Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
Aydin-Sayitoglu M, Hatirnaz O, Erensoy N, Ozbek U.
Am J Hematol 81(3):162-70. 2006
4CYP2D6, CYP2D6DM, CYP2D7P1
A frameshift mutation and alternate splicing in human brain generate a functional form of the pseudogene cytochrome P4502D7 that demethylates codeine to morphine.
Pai HV, Kommaddi RP, Chinta SJ, Mori T, Boyd MR, Ravindranath V.
J Biol Chem 279(26):27383-9. Epub 2004 Mar 29. 2004
5CYP2D6
Polymorphisms of the CYP2D6 gene increase susceptibility to ankylosing spondylitis.
Brown MA, Edwards S, Hoyle E, Campbell S, Laval S, Daly AK, Pile KD, Calin A, Ebringer A, Weeks DE, Wordsworth BP.
Hum Mol Genet 9(11):1563-6. 2000
6CYP2D6, NAGA, SREBF2, TSG22C
Refinement of an ovarian cancer tumour suppressor gene locus on chromosome arm 22q and mutation analysis of CYP2D6, SREBP2 and NAGA.
Bryan EJ, Thomas NA, Palmer K, Dawson E, Englefield P, Campbell IG.
Int J Cancer 87(6):798-802. 2000
7CYP2D6, GSTM1, NAT2
Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias.
Lemos MC, et al.
Carcinogenesis 20(7):1225-9 1999
8CYP2D6
Mutation involving cytochrome P450IID6 in two Japanese patients with neuroleptic malignant syndrome.
Kawanishi C, Shimoda Y, Fujimaki J, Onishi H, Suzuki K, Hanihara T, Sugiyama N, Kosaka K.
J Neurol Sci 160 : 102-104. 1998
9CYP24A1, CYP26A1, CYP27A1, CYP27B1, CYP2A, CYP2@, CYP2A13, CYP2A6, CYP2A7, CYP2A7P1, CYP2B, CYP2B6, CYP2B7P1, CYP2C@, CYP2C18, CYP2C19, CYP2C8, CYP2C9, CYP2D@, CYP2D6, CYP2D7P1, CYP2D7P2, CYP2D8P1, CYP2D8P2, CYP2E1, CYP2F1, CYP2F1P, CYP2G1P, CYP2G2P, CYP2J2, CYP2S1, CYP2T2P, CYP2T3P
Molecular genetics of the human cytochrome P450 monooxygenase superfamily.
Smith G, Stubbins MJ, Harries LW, Wolf CR.
Xenobiotica 28(12):1129-65. Review. No abstract available. 1998
10CYP2D6
An inactive cytochrome P450 CYP2D6 allele containing a deletion and a base substitution.
Daly AK, et al.
Hum Genet 95 : 337-341. 1995
11CYP2D6
A nonsense mutation in the cytochrome P450 CYP2D6 gene identified in a Caucasian with an enzyme deficiency.
Broly F, et al.
Hum Genet 96 : 601-603 1995
12CYP2D6
Homologous unequal cross-over involving a 2.8 kb direct repeat as a mechanism for the generation of allelic variants of the human cytochrome P450 CYP2D6 gene.
Steen VM, et al.
Hum Mol Genet 4 : 2251-2257. 1995
13CYP2D6
A BamHI polymorphism in the human cytochrome P450 gene, CYP2D6.
Morimoto Y, et al.
Clin Genet 47 : 103-104. 1995
14CYP2D6, CYP2D6DM
Identification of a new variant CYP2D6 allele with a single base deletion in exon 3 and its association with the poor metabolizer phenotype.
Saxena R, Shaw GL, Relling MV, Frame JN, Moir DT, Evans WE, Caporaso N, Weiffenbach B.
Hum Mol Genet 3 : 923-926. 1994
15CYP2D6, CYP2D6DM
DNA haplotype-dependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6) : evidence for two major allozymes in extensive metabolisers.
Panserat S, et al.
Hum Genet 94 : 401-406. 1994
16CYP2D6
Localization of the CYP2D gene locus to human chromosome 22q13.1 by polymerase chain reaction, in situ hybridization, and linkage analysis.
Gough AC, et al.
Genomics 15 : 430-432. 1993
17CYP2D6
Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.
Johansson I, et al.
Proc Natl Acad Sci U S A 90 : 11825-11829. 1993
18CYP2D6
A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease.
Tsuneoka Y, et al.
J Biochem (Tokyo) 114 : 263-266. 1993
19CYP2D6
DNA haplotype dependency of debrisoquine 4-hydroxylase (CYP2D6) expression among extensive metabolisers.
Mura C, et al.
Hum Genet 92 : 367-372. 1993
20CYP2D6
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease.
Smith CAD, et al.
Lancet 339 : 1375-1377. 1992
21CYP2D6
Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility.
Wolf CR, et al.
Carcinogenesis 13 : 1035-1038. 1992
22CYP2D6
Dinucleotide repeat polymorphism at the debrisoquine 4-hydroxylase (CYP2D) locus.
Trofatter JA, et al.
Nucleic Acids Res 19 : 2802. 1991
23CYP2D6
Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism.
Gaedigk A, et al.
Am J Hum Genet 48 : 943-950. 1991
24CYP2D6, CYP2D6DM
Debrisoquine/sparteine hydroxylation genotype and phenotype : analysis of common mutations and alleles of CYP2D6 in a european population.
Broly F, et al.
DNA Cell Biol 10 : 545-558. 1991
25CYP2D6
NcoI RFLP in the pseudogene (CYP2D8P) of the human debrisoquine 4-hydroxylase locus.
Mura C, et al.
Nucleic Acids Res 19 : 1162. 1991
26CYP2D6
Dinucleotide repeat polymorphism at the human debrisoquine 4-hydroxylase (CYP2D) locus.
Polymeropoulos MH, et al.
Nucleic Acids Res 19 : 1961. 1991
27CYP2D6, CYP2D6DM
Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification.
Heim M, et al.
Lancet 336 : 529-532. 1990
28CYP2D6
Xba1 16-plus 9-kilobase DNA restriction fragments identify a mutant allele for debrisoquin hydroxylase: report of a family study.
Evans WE, et al.
Mol Pharmacol 37 : 639-642. 1990
29CYP2D6, CYP2D6DM
Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes.
Kagimoto M, et al.
J Biol Chem 265 : 17209-17214. 1990
30CYP2D6
Identification of the primary gene defect at the cytochrome P450 CYP2D locus.
Gough AC, et al.
Nature 347 : 773-776. 1990
31CYP2D6, CYP2D6DM
The human CYP2D locus associated with a common genetic defect in drug oxidation: A G1934-A base change in intron 3 of a mutant CYP2D6 allele results in an aberrant 3' splice recognition site.
Hanioka N, et al.
Am J Hum Genet 47 : 994-1001. 1990
32XRCC6, CYP2D6
Localization of TSHR gene and cytochrome p450 IID subfamily on chromosome 22 by linkage analysis.
Mitchell AL, et al.
(HGM10) Cytogenet Cell Genet 51 : 1045. 1989
33CYP2D6, CYP2D8P2
The human debrisoquine 4-hydroxylase (CYP2D) locus : sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene.
Kimura S, et al.
Am J Hum Genet 45 : 889-904. 1989
34CYP2D6, CYP2D6DM
Characterization of the common genetic defect in humans deficient in debrisoquine metabolism.
Gonzalez FJ, et al.
Nature 331 : 442-446. 1988
35CYP2D6
Human debrisoquine 4-hydroxylase (P450IID1) : cDNA and deduced amino acid sequence and assignment of CYP2D locus to chromosome 22.
Gonzalez FJ, et al.
Genomics 2 : 174-179. 1988
36CYP2D6
Chromosomal assignment of human cytochrome P-450 (debrisoquine/spartein type) to chromosome 22.
Eichelbaum M, et al.
(HGM9) Cytogenet Cell Genet 46 : 610. 1987